Tanya Lewis's Net Worth
$1.75 Million
Who is Tanya Lewis?
Tanya Lewis has an estimated net worth of $1.75 Million. This is based on reported shares across multiple companies, which include Karyopharm Therapeutics Inc., Replimune Group, Inc., DiaMedica Therapeutics Inc., and VION PHARMACEUTICALS INC.
SEC CIK
Tanya Lewis's CIK is 0001451038
Past Insider Trading and Trends
2021 was Tanya Lewis's most active year for acquiring shares with 6 total transactions. Tanya Lewis's most active month to acquire stocks was the month of January. 2023 was Tanya Lewis's most active year for disposing of shares, totalling 3 transactions. Tanya Lewis's most active month to dispose stocks was the month of January. 2021 saw Tanya Lewis paying a total of $0.00 for 287,464 shares, this is the most they've acquired in one year. In 2023 Tanya Lewis cashed out on 25,067 shares for a total of $529,731.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $1.53
EVP, Chief Reg. Affairs
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +94.12% | 22.01K |
—
|
—
| 45.4K |
Feb 25
| |||
Form 4
| -33.06% | -2.05K |
$15.52 | -$31,752.08 | 4.14K |
Feb 11
| |||
Form 4
| +1,048.24% | 5.65K |
—
|
—
| 6.19K |
Feb 5
| |||
Form 4
|
∞
| 539 |
$15.58 | -$3,521.08 | 539 |
Oct 28 - Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Replimune Group, Inc. (REPL) Snapshot price: $7.66
Chief Dev. Op. Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.68% | -12.86K |
$24.06 | -$309,394.95 | 135.29K |
Jun 13
| |||
Form 4
| -7.61% | -12.21K |
$18.05 | -$220,336.35 | 148.15K |
May 16
| |||
Form 4
| +33.23% | 40K |
—
|
—
| 160.36K |
Apr 1
| |||
Form 4
| -4.35% | -5.47K |
$14.59 | -$79,851.07 | 120.36K |
May 16
| |||
Form 4
| +71.59% | 52.5K |
—
|
—
| 125.83K |
Apr 1
| |||
Form 4
|
∞
| 73.33K |
—
|
—
| 73.33K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DiaMedica Therapeutics Inc. (DMAC) Snapshot price: $3.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VION PHARMACEUTICALS INC No price found
VP Regulatory and Quality
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||